Stock Events

Stock Events

Cardiol Therapeutics (CRDL.TO) Q4 2024 Earnings

14NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.19

-0.16

-0.13

-0.1

Details

Expected EPS

-0.13244858937355503

Actual EPS

-0.18707868270000003

Surprise EPS

-0.05

Surprise Percent

+41.25%

Description

Cardiol Therapeutics (CRDL.TO) has reported earnings of -0.18707868270000003 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.